NOVO NORDISK INC. V. AUROBINDO PHARMA LTD. , No. 12-1388 (Fed. Cir. 2012)

Annotate this Case

Download PDF

Case: 12-1388 Document: 28 Page: 1 Filed: 09/26/2012 NOTE: This order is nonprecedential. Wntteb ~tate~ QCourt of §ppeaI~ for tbe jfeberaI QCircuit NOVO NORDISK INC. AND NOVO NORDISK A1S, Plaintiffs-Appellants, v. AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA USA, INC., Defendants-Appellees. 2012-1388 Appeal from the United States District Court for the District of New Jersey in case no. 12-CV-1026, Judge Freda L. Wolfson. ON MOTION ORDER The parties jointly move to stay proceedings in this appeal pending the final disposition of Novo Nordisk AIS v. Caraco Pharmaceutical Laboratories, Ltd., No. 20111223. Upon consideration thereof, Case: 12-1388 Document: 28 Page: 2 Filed: 09/26/2012 2 NOVO NORDISK INC. V. AUROBINDO PHARMA LTD. IT Is ORDERED THAT: (1) The motion to stay proceedings in 2012-1388 is granted. The parties are directed to inform this court within 10 days of the final disposition of 2011-1223 how they believe this appeal should proceed. (2) A copy of this order shall be transmitted to the merits panel assigned to Novo Nordisk AIS v. Caraco Pharmaceutical Laboratories, Ltd., No. 2011-1223. FOR THE COURT SEP 262012 Date cc: Mark Andrew Perry, Esq. Edward John Pardon, Esq. s26 /s/ Jan Horbaly Jan Horbaly Clerk FILED u.s.THE FEDERAL CIRCUITFOR COURT OF APPEALS SEP 26 ZOlZ JAN HORBALY Cl£RK

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.